GH

Guardant Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

79.98
-1.52
-1.87%
Opening 13:45 02/27 EST
OPEN
77.70
PREV CLOSE
81.50
HIGH
83.17
LOW
75.22
VOLUME
1.60M
TURNOVER
--
52 WEEK HIGH
112.22
52 WEEK LOW
54.75
MARKET CAP
6.68B
P/E (TTM)
-95.3619
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average GH stock price target is 112.57 with a high estimate of 135.00 and a low estimate of 85.00.

EPS

GH News

More
  • Stocks making the biggest moves midday: Moderna, Sabre, TJX, Netflix & more
  • CNBC.com · 1d ago
  • Guardant Health, Inc. Just Reported, And Analysts Assigned A US$113 Price Target
  • Simply Wall St. · 1d ago
  • Why Guardant Stock Just Popped 10%
  • MotleyFool.com · 1d ago
  • Here's Why Guardant Health Tumbled Today
  • MotleyFool.com · 2d ago

Industry

Biotechnology & Medical Research
-2.06%
Pharmaceuticals & Medical Research
-1.40%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About GH

Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant360 is a molecular diagnostic test that measures 73 cancer-related genes from circulating tumor deoxyribonucleic acid (ctDNA). Its Guardant360 process includes blood collection, laboratory processing, analysis and reporting. Guardant360 is used for a range of applications, including translational science research and identifying target patient populations, drug development and commercialization post-drug approval.
More

Webull offers kinds of Guardant Health Inc stock information, including NASDAQ:GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions.